Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (191-200 of 443) with videos related to

Pageof 45
Sort By:
Bone Marrow Transplantation|December 2, 2022
Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
Cancer Medicine|July 27, 2022
Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMTArnon Nagler, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
American Journal of Hematology|October 4, 2017
Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)Vladimir Lj Lazarevic, Myriam Labopin, Wu Depei, et al.
Bone Marrow Transplantation|May 4, 2020
Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMTZinaida Peric, Myriam Labopin, Christophe Peczynski, et al.
American Journal of Hematology|June 15, 2017
Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSandra Eder, Jonathan Canaani, Eric Beohou, et al.
Clinical & Translational Immunology|October 2, 2020
High-dose post-transplant cyclophosphamide impairs γδ T-cell reconstitution after haploidentical haematopoietic stem cell transplantation using low-dose antithymocyte globulin and peripheral blood stem cell graftNicolas Stocker, Béatrice Gaugler, Myriam Labopin, et al.
Bone Marrow Transplantation|November 29, 2020
Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMTAnnalisa Paviglianiti, Myriam Labopin, Didier Blaise, et al.
Bone Marrow Transplantation|September 21, 2018
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective studyFrancesca Bonifazi, Elisa Dan, Myriam Labopin, et al.
Bone Marrow Transplantation|August 18, 2024
Young (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Haematologica|May 2, 2020
Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemiaArnon Nagler, Abraham S Kanate, Myriam Labopin, et al.
Pageof 45

Showing results (191-200 of 443) with videos related to

Sort By:
Pageof 45
Bone Marrow Transplantation|December 2, 2022
Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
Cancer Medicine|July 27, 2022
Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMTArnon Nagler, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
American Journal of Hematology|October 4, 2017
Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)Vladimir Lj Lazarevic, Myriam Labopin, Wu Depei, et al.
Bone Marrow Transplantation|May 4, 2020
Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMTZinaida Peric, Myriam Labopin, Christophe Peczynski, et al.
American Journal of Hematology|June 15, 2017
Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSandra Eder, Jonathan Canaani, Eric Beohou, et al.
Clinical & Translational Immunology|October 2, 2020
High-dose post-transplant cyclophosphamide impairs γδ T-cell reconstitution after haploidentical haematopoietic stem cell transplantation using low-dose antithymocyte globulin and peripheral blood stem cell graftNicolas Stocker, Béatrice Gaugler, Myriam Labopin, et al.
Bone Marrow Transplantation|November 29, 2020
Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMTAnnalisa Paviglianiti, Myriam Labopin, Didier Blaise, et al.
Bone Marrow Transplantation|September 21, 2018
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective studyFrancesca Bonifazi, Elisa Dan, Myriam Labopin, et al.
Bone Marrow Transplantation|August 18, 2024
Young (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Haematologica|May 2, 2020
Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemiaArnon Nagler, Abraham S Kanate, Myriam Labopin, et al.
Pageof 45